RNA Virus - Myxovirus Flashcards
Myxovirus includes
Orthomyxovirus
Paramyxovirus
Members of Orthomyxovirus family
Influenza A, B and C
Members of Paramyxovirus family
M - Measles
M - Mumps
R - Respiratory Synctial virus
Parainfluenza
Nipah virus
Size and RNA form of Orthomyxovirus and Paramyxovirus
Orthomyxovirus - size : 110nm
RNA - Segmented
Paramyxovirus - Size : 150nm
RNA - unsegmented
Symmetry, RNA sense of Orthomyxovirus and Paramyxovirus
Both have helical symmetry
Both are enveloped
Both have Negative sense RNA
Types of Influenza viruses
Influenza A - 8
Influenza B - 8
Influenza C - 7
Structure seen on Influenza viruses
Hemagglutinin (HA)
Neuraminidase (NA)
M1 And M2 Protein
Hemagglutinin shape and attaches to
More in number
Triangular in shape
Attachment to Sialyl acid receptor (Resp. Epithelium, RBC)
Neuraminidase Shape and functions
AKA
Less in no.
Mushroom shaped
Helps in release of virus
AKA - Receptor destroying enzyme (RDE) or Sialidase
M1 protein function
Beneath envelope
Maintains structural integrity
M2 protein Features
Ion channel - H+ influx
Aid in uncoating of virus
Pathogenesis of Influenza viruses
Attachment of Hemagglutinin on Sialyc acid receptor - internalized by endocytosis - Uncoating (by M2 protein by causing H+ influx) - Then negative sense RNA is converted to Positive RNA sense with help of RNA Dependent RNA Polymerase - release of virus with the help of Neuraminidase
Group specific typing of Influenza viruses
1);Influenza virus A - Human and animals, Antigenic shift, Epidemic and Pandemic
2) Influenza virus B - Humans only, No antigenic shift, Seasonal flu
3) Influenza Virus C - Non pathogenic
Difference between antigenic shift and antigenic drift
1) Antigenic shift : Sudden change
Antigenic drift : Gradual change
2) Antigenic shifting : Exchange of RNA segments b/w Influenza A (Genetic reasortment)
Antigenic drift : Mutation in H and N
3) Antigenic shift : cause major epidemics and Pandemics
Antigenic drift - doesn’t cause
4) Antigenic shift - Seen in Influenza A
Antigenic drift - seen in Influenza A and B
Currently circulating strains of Influenza viruses
Type A/H1N1 : WHO declared in pandemic on 11th June 2009
Type A/H3N2
Type A/H5N1
Type B
Incubation period of Influenza viruses
18-72 hours
Clinical features of Influenza
Fever, headache
Sore throat
Myalgia
Runny nose is usually absent
Rarely GI Symptoms
Reye Syndrome AKA Jamshedpur fever
Complication and M/C Extrapulmonary symptom of Influence
Complication - Pneumonia
M/C extrapulmonary symptoms - Myalgia
Influenza samples are stored in which media
VTM (Viral transport media)
Isolation of Influenza is done on
Amniotic cavity of embryonated egg
Cell lines (1° Monkey kidney)
Antigen detection test for Influenza
Direct immunofluorescence
Antibody detection of Influenza
ELISA - 2 sample to be taken with gap of 2 weeks - 4 fold gap increase
Hemagglutination Inhibition test (HAI)
Hemagglutination Inhibition test Procedure
1) RBC - No reaction
2) RBC + virus (influenza) - Hemagglutination - Mat/Carpet Formation
3) RBCs + virus + Antibody (pt. Sample) - Antibody combines with Antigen - Hemagglutination Inhibition
Which tests are sensitive and specific for Influenza
RT PCR
Real Time PCR
Neuraminidase inhibitors given by oral route
Tamiflu/Oseltamivir
Neuraminidase inhibitor given by Inhalation route
Zanamivir/Relenza
M2 Inhibitors used for Influenza A
Amantadine
Rimantidine
Vaccines used against Influenza
Live Nasal spray -
Inactivated vaccine - Given to healthcare professionals, two doses given annually
Live Nasal spray vaccine for Influenza indications and C/I
Trivalent vaccine - H1N1, H3N2 and Type B
Indicated - 2-49 years of age
C/I - if low immunity